Federal Supply Schedule V797D70098
- This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Aquestive Therapeutics, Inc. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products, under FSS Contract 65 I B. The contract has a ceiling value of $1,000,000.00 and a period of performance extending to March 31, 2030. As a multiple award FSS contract, this vehicle allows the VA and other federal agencies to procure the specified pharmaceutical and drug...
- This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
- This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
- The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024. The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to Saptalis Pharmaceuticals, LLC, a small disadvantaged business. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a ceiling value of $565,000.00 and a period of performance through March 14, 2030. The contract was awarded on March 15, 2025 through a...
- This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
- The Federal Supply Schedule (FSS) contract awarded to Exela Pharma Sciences, LLC by the U.S. Department of Veterans Affairs (VA) for Veterans Integrated Service Network 12 has a total ceiling value of $20,304,570.00 and a period of performance from September 29, 2024, to September 30, 2029. This multiple-award contract allows the VA to efficiently procure a wide range of drugs, pharmaceuticals, and hematology-related products from Exela Pharma Sciences to support the healthcare operations and...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70098Federal Supply Schedule
- Blanket Purchase Agreements
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Aprecia Pharmaceuticals Company, a manufacturer of pharmaceutical goods. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS schedule 65 I B, with a contract ceiling value of $9,000,000 and a period of performance from March 1, 2017 to February 28, 2026. The contract is a multiple award vehicle, meaning it allows for orders to be placed with Aprecia as well as other pre-qualified vendors on the FSS. As a pharmaceutical manufacturer, Aprecia's products and services under this contract are likely to include a range of drugs, pharmaceuticals, and related medical supplies. The contract is not set aside for any particular business type. The VA's Veterans Integrated Service Network 12 will be the primary funding agency and end user for orders placed against this FSS contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00016 | Supplemental Agreement for work within scope | $0 | 9/30/25 | |
| P00015 | Supplemental Agreement for work within scope | $0 | 2/11/25 | |
| P00014 | Supplemental Agreement for work within scope | $0 | 12/3/24 | |
| P00013 | Supplemental Agreement for work within scope | $0 | 6/12/24 | |
| P00012 | Supplemental Agreement for work within scope | $0 | 2/14/24 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Aprecia Pharmaceuticals Company 65IB, V797D-70098 Effective, 03/01/2017 - 02/28/2022 | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 2/22/17, 11:12 AM |